← Open Payments lookup

CANDICE COLEMAN: Open Payments

NPI 1073912366 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,036 in 27 payments from 9 companies in 2025. Trend: 2023 $153 · 2024 $626 · 2025 $1,036

Food & beverage: $1,036
CompanyPaymentsAmount
Gilead Sciences, Inc.10$262
AstraZeneca Pharmaceuticals LP2$221
Abbott Laboratories2$192
Boehringer Ingelheim Pharmaceuticals, Inc.2$135
ABBVIE INC.4$68
Novo Nordisk Inc3$63
PFIZER INC.2$49
Merck Sharp & Dohme LLC1$29
Boston Scientific Corporation1$18

Products named: BREZTRI, FREESTYLE LIBRE 3, JARDIANCE, Biktarvy, VRAYLAR, PREVNAR 20, Ozempic, PIFELTRO.

Industry payments across MS — which companies pay providers there.